http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112013010718-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a95d0c63b9b3f2bc8e8d6b45fbe7789 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 |
| filingDate | 2011-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_999feb909266ed9812eb5ef0c3c2891e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfcdcf47a19d0b9714f1e7e04df2fe64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c59f29b6440930c0cc6efa58f68dece4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fbf9e85765d66ba505ec836b4e39b18 |
| publicationDate | 2020-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-112013010718-A2 |
| titleOfInvention | pan-her antibody composition, pharmaceutical composition, method for producing and using said composition |
| abstract | pan-her antibody composition. the present invention is directed to improved therapies against receptors within the egfr / erbb / her family that most widely interfere with multiple members of the her family (pan-her inhibition). more particularly, the invention is directed to the use of antibody composition for human cancer therapy. in vitro studies have shown that the antibody composition of the invention targeting multiple receptors in the hers family is superior to the antibody composition targeting only one receptor in the her family. |
| priorityDate | 2010-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 288.